首页> 美国卫生研究院文献>Nucleic Acids Research >Initiator protein dimerization plays a key role in replication control of Vibrio cholerae chromosome 2
【2h】

Initiator protein dimerization plays a key role in replication control of Vibrio cholerae chromosome 2

机译:起始蛋白二聚化在霍乱弧菌2号染色体的复制控制中起关键作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

RctB, the initiator of replication of Vibrio cholerae chromosome 2 (chr2), binds to the origin of replication to specific 12-mer sites both as a monomer and a dimer. Binding to 12-mers is essential for initiation. The monomers also bind to a second kind of site, 39-mers, which inhibits initiation. Mutations in rctB that reduce dimer binding increase monomer binding to 12-mers but decrease monomer binding to 39-mers. The mechanism of this paradoxical binding behavior has been unclear. Using deletion and alanine substitution mutants of RctB, we have now localized to a 71 amino acid region residues important for binding to the two kinds of DNA sites and for RctB dimerization. We find that the dimerization domain overlaps with both the DNA binding domains, explaining how changes in the dimerization domain can alter both kinds of DNA binding. Moreover, dimerization-defective mutants could be initiation-defective without apparent DNA binding defect. These results suggest that dimerization might be important for initiation beyond its role in controlling DNA binding. The finding that determinants of crucial initiator functions reside in a small region makes the region an attractive target for anti-V. cholerae drugs.
机译:RctB是霍乱弧菌2号染色体(chr2)复制的发起者,它以单体和二聚体的形式与特定12-聚体位点的复制起点结合。结合至12聚体对于引发是必不可少的。单体还结合第二种位点,即39-聚体,它抑制了起始。 rctB中减少二聚体结合的突变增加了单体与12-mer的结合,但降低了单体与39-mer的结合。这种矛盾的结合行为的机制尚不清楚。使用RctB的缺失和丙氨酸取代突变体,我们现在已经定位到71个氨基酸区域的残基,这些残基对于结合两种DNA位点和RctB二聚化很重要。我们发现二聚化结构域与两个DNA结合结构域重叠,解释了二聚化结构域的变化如何改变两种DNA的结合。而且,二聚化缺陷突变体可以是起始缺陷,而没有明显的DNA结合缺陷。这些结果表明,二聚化作用可能超出其在控制DNA结合中的作用,对于引发作用可能很重要。关键引发剂功能的决定因素位于一个小区域的发现使该区域成为抗V的诱人靶标。霍乱药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号